SPPL2B
Signal peptide peptidase-like 2B
Also known as: IMP4, KIAA1532, PSL1, SPP2B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TCT7
- Gene
- SPPL2B
- Ensembl
- ENSG00000005206
- Chromosome
- 19
- Canonical length
- 592 aa
- Protein class
- Enzymes, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Centrosome
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the GXGD family of aspartic proteases. The GXGD proteases are transmembrane proteins with two conserved catalytic motifs localized within the membrane-spanning regions. This enzyme localizes to endosomes, lysosomes, and the plasma membrane. It cleaves the transmembrane domain of tumor necrosis factor alpha to release the intracellular domain, which triggers cytokine expression in the innate and adaptive immunity pathways. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
592 residues, UniProt reviewed canonical sequence.
>Q8TCT7|SPPL2B
1 MAAAVAAALA RLLAAFLLLA AQVACEYGMV HVVSQAGGPE GKDYCILYNP QWAHLPHDLS
61 KASFLQLRNW TASLLCSAAD LPARGFSNQI PLVARGNCTF YEKVRLAQGS GARGLLIVSR
121 ERLVPPGGNK TQYDEIGIPV ALLSYKDMLD IFTRFGRTVR AALYAPKEPV LDYNMVIIFI
181 MAVGTVAIGG YWAGSRDVKK RYMKHKRDDG PEKQEDEAVD VTPVMTCVFV VMCCSMLVLL
241 YYFYDLLVYV VIGIFCLASA TGLYSCLAPC VRRLPFGKCR IPNNSLPYFH KRPQARMLLL
301 ALFCVAVSVV WGVFRNEDQW AWVLQDALGI AFCLYMLKTI RLPTFKACTL LLLVLFLYDI
361 FFVFITPFLT KSGSSIMVEV ATGPSDSATR EKLPMVLKVP RLNSSPLALC DRPFSLLGFG
421 DILVPGLLVA YCHRFDIQVQ SSRVYFVACT IAYGVGLLVT FVALALMQRG QPALLYLVPC
481 TLVTSCAVAL WRRELGVFWT GSGFAKVLPP SPWAPAPADG PQPPKDSATP LSPQPPSEEP
541 ATSPWPAEQS PKSRTSEEMG AGAPMREPGS PAESEGRDQA QPSPVTQPGA SALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPPL2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 9
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 61 nTPM
Expression across tissuesHPA
Tissue
- testis: 61 nTPM
- pituitary gland: 59 nTPM
- cerebellum: 50 nTPM
- small intestine: 49 nTPM
- pancreas: 46 nTPM
- colon: 40 nTPM
Single-cell type
- late spermatids: 168 nCPM
- late primary spermatocytes: 111 nCPM
- astrocytes: 100 nCPM
- foveolar cells: 88 nCPM
- tuft cells: 81 nCPM
- ependymal cells: 79 nCPM
Immune cell
- plasmacytoid DC: 17 nTPM
- naive B-cell: 13 nTPM
- basophil: 12 nTPM
- myeloid DC: 9.4 nTPM
- memory B-cell: 8.2 nTPM
- classical monocyte: 7.7 nTPM
Brain region
- medulla oblongata: 44 nTPM
- choroid plexus: 41 nTPM
- white matter: 37 nTPM
- pons: 37 nTPM
- midbrain: 37 nTPM
- cerebellum: 36 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.98
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- membrane protein ectodomain proteolysis
- membrane protein intracellular domain proteolysis
- membrane protein proteolysis
- regulation of immune response
- regulation of tumor necrosis factor-mediated signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SPPL2B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPPL2B as an antibody target. Whether an autoantibody or antibody against SPPL2B could matter depends on whether native SPPL2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPPL2B is annotated at the cell surface, where native SPPL2B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SPPL2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...